查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561601

2024-2032 年按產品、應用、組織類型和地區分類的組織銀行市場報告

Tissue Banking Market Report by Product, Application, Tissue Type, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2023 年，全球組織庫IMARC Group規模達到 18 億美元。新興的研發（R＆D）投資、冷凍保存的進步、慢性病和遺傳性疾病的增加、對個人化醫療的需求不斷成長、基因組學的改進、監管的進步、戰略合作以及研究人員意識的增強是推動這一趨勢的一些因素。

組織銀行市場分析：

  • 主要市場促進因素：再生醫學的快速進步和器官移植手術的日益普及推動了全球組織庫市場的發展。政府採取的越來越多的舉措以及人們對組織捐贈的認知不斷提高是預計推動市場成長的其他因素。此外，人們越來越關注開發更可行且保存期限更長的組織保存和儲存技術，這是市場的另一個成長誘導因素。隨著慢性病和創傷病例的增加，組織庫的需求呈指數級成長，這是刺激市場成長的另一個因素。除此之外，擴大醫療基礎設施，特別是在發展中國家，正在促進市場成長。其他因素，例如對生物庫和個人化醫療的投資增加以及研究機構和組織庫之間的合作不斷升級，正在促進市場成長。
  • 主要市場趨勢：自動化組織處理和保存系統的發展是主要市場趨勢之一，它有助於最大限度地減少處理過程所需的時間，並減少人為錯誤。在組織銀行中不斷使用人工智慧 (AI) 和機器學習 (ML) 來改善資料管理，為市場成長創造了積極的前景。與此一致的是，嚴格的道德法規迫使紙巾烘焙企業標準化其營運，這進一步推動了市場的成長。此外，生物製藥公司和組織庫之間不斷升級的合作以及對冷凍保存方法的日益關注正在推動市場的成長。
  • 地理趨勢：北美在全球組織銀行市場中佔據領先佔有率，因為它擁有強大的醫療基礎設施、更高的組織捐贈意識以及對醫學研究的大量投資。該地區的主導地位也歸功於主要市場參與者的強大存在和先進的技術能力。有利的政府環境和健全的公共衛生系統推動了歐洲市場的成長。亞太地區的組織庫市場受到不斷成長的醫療保健支出、不斷擴大的生物庫計劃以及不斷成長的組織移植數量的推動。
  • 競爭格局：組織庫產業的一些主要市場參與者包括 AMS Biotechnology、Beckman Coulter Inc.（Danaher Corporation）、Bio-Rad Laboratories Inc.、Brooks Life Sciences Inc.（Brooks Automation Inc.）、Eppendorf AG、Merck KGaA、 PHC Corporation、QIAGEN NV、Sartorius AG、Taylor-Wharton、Thermo Fisher Scientific Inc.、VWR International LLC (Avantor Inc) 等。
  • 挑戰與機會：為市場帶來挑戰的因素包括嚴格的監管要求、組織捐贈和處理的道德問題以及複雜儲存方法的高成本。儲存組織的品質和安全無疑是首要關注的問題，這需要遵守嚴格的標準。由於意識水平低和文化障礙，一些地區的組織捐贈率有限。然而，它們也為市場發展提供了各種機會，例如由於公眾意識和教育的迅速發展而導致組織捐贈率不斷增加。負擔能力是保存技術和儲存解決方案提供者可以考慮解決的另一個因素。

組織銀行市場趨勢：

增加研發投資

全球組織庫市場的成長主要是由研發投資的增加所推動的，特別是在再生醫學和個人化治療方面。隨著科學界和醫學界對疾病認知和治療的進步，組織樣本捐贈顯著成長，這進一步推動了市場的成長。這些樣本對於了解疾病的生物學、測試新藥在患者中的潛在用途以及確定可能受益於特定藥物的患者群體至關重要。隨著幹細胞治療和基因編輯等領域的研究取得進展，它增加了對特定組織樣本的依賴，進一步增加了對每個人都可以存取的保存完好的組織庫的需求。例如，最近，加州大學舊金山分校推出了世界上第一個組織庫，其中包含長期新冠患者捐贈的樣本。先前的研究表明，這種病毒可以繼續在全身徘徊，可能是了解這種使人衰弱的疾病的原因並找到有效治療方法的關鍵。

低溫保存技術的進步

低溫保存技術的發展是推動全球組織庫市場的主要因素之一。冷凍保存是在冰點以下儲存活體組織和細胞並保持其活力的有效方法。快速發展的技術加速了這個過程，使保存組織的品質及其耐用性變得更好。此外，還開發了新的冷凍保護劑和冷卻技術，例如防止冰晶形成的玻璃化，否則會損壞細胞結構。此外，冷凍保存的自動化進一步實現了操作自動化，有助於最大限度地減少人為錯誤並提高吞吐量，從而促進了市場的成長。

慢性病和遺傳性疾病的盛行率不斷上升

遺傳疾病和慢性病發病率的不斷上升是加速全球組織庫市場發展的主要因素之一。根據對沙烏地阿拉伯人口進行的全國調查，成年男性和女性的糖尿病（DM）盛行率估計為男性14.8%，而女性則較低，為11.7%。癌症、心血管疾病和糖尿病等慢性疾病需要廣泛的研究來了解其病理生理學並開發有效的治療方法。組織庫透過提供多種生物樣本為這項研究提供關鍵資源，這對於研究疾病機制、開發新藥和測試治療效果至關重要。

組織銀行市場區隔：

IMARC Group提供了每個細分市場的主要趨勢的分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品、應用和紙巾類型對市場進行了分類。

按產品分類：

  • 裝置
    • 冷凍保存設備
    • 解凍設備
    • 品質管制設備
    • 其他
  • 介質和耗材

設備佔大部分市場佔有率

該報告根據產品提供了詳細的市場細分和分析。這包括設備（冷凍保存設備、解凍設備、品質控制設備等）以及介質和消耗品。報告稱，設備佔最大部分。

對先進可靠的組織保存和分析系統的需求不斷成長，推動了設備領域的發展。自動化和改進的冷凍保存技術等技術進步對於提高組織處理和儲存的效率和準確性至關重要。研究活動和臨床試驗的增加需要最先進的設備來確保高品質和可重複的結果。此外，對個人化醫療和再生療法的日益關注推動了對能夠管理多樣化和複雜組織樣本的專用設備的需求。品質和安全標準的監管要求進一步推動了精密設備的採用。對醫療保健基礎設施的投資增加和全球組織庫的擴張也促進了對先進設備的需求。

按應用分類：

  • 療法
  • 醫學研究
  • 其他

治療藥物佔業界最大佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括治療、醫學研究等。報告稱，治療藥物佔據最大的市場佔有率。

治療領域受到對個人化醫療日益成長的需求的推動，這需要使用特定的、高品質的組織樣本來根據個別基因圖譜量身定做治療方案。基因組學和生物技術的進步進一步推動了這種成長，因為它們使研究人員和臨床醫生能夠更好地了解複雜的疾病機制並開發有針對性的療法。此外，慢性病和遺傳性疾病盛行率的上升加速了對創新治療解決方案的需求，導致研發活動激增。藥物發現的技術進步，包括高通量篩選和複雜的生物資訊工具，也至關重要，因為它們依賴多樣化且特徵良好的生物樣本來識別和驗證新的治療標靶。人們對再生醫學和細胞療法（例如幹細胞治療和組織工程）的日益重視，推動了對強大的組織庫基礎設施的需求，而組織庫基礎設施為這些尖端療法提供了必要的材料。

按組織類型分類：

  • 心血管組織
  • 肺組織
  • 腎臟組織
  • 胰臟組織
  • 肝臟組織
  • 眼組織
  • 其他

心血管組織代表領先的細分市場

該報告根據衛生紙類型提供了詳細的市場細分和分析。這包括心血管組織、肺組織、腎臟組織、胰臟組織、肝臟組織、眼部組織等。根據該報告，心血管組織佔最大部分。

心血管組織領域是由心血管疾病（CVD）盛行率不斷上升所驅動的，心血管疾病是全球死亡的主要原因之一。 CVD病例的激增需要廣泛的研究和開發工作，從而刺激了對高品質心血管組織的需求，以用於研究疾病機制、開發創新療法和測試治療干預措施。組織工程和再生醫學的進步也至關重要，因為它們使得心血管組織的創建和使用能夠用於開發個人化療法和改善患者的治療結果。對個人化醫療的日益重視進一步推動了需求，因為臨床醫生尋求與患者個人資料相符的組織樣本，以製定更有效的治療計劃。此外，生物樣本庫技術的不斷進步，包括改進的保存方法和更好的組織表徵技術，提高了心血管組織的品質和可用性。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美市場領先，佔據最大的組織銀行市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。根據該報告，北美是組織銀行最大的區域市場。

北美區域市場受到醫療保健研究和生物技術投資不斷增加的推動，這大大增加了對高品質組織樣本的需求。該地區先進的研究機構和強大的製藥業的存在加速了對維護良好的組織庫的需求，以支持再生醫學、個人化治療和藥物開發的創新研究。此外，北美慢性病和遺傳性疾病的日益普及推動了對不同組織樣本的需求，以了解疾病機制並開發有效的治療方法。冷凍保存和組織儲存的技術進步進一步增強了市場，提供了延長保存組織活力並提高整體研究品質的解決方案。北美的監管環境也發揮著至關重要的作用；嚴格的標準和準則確保組織庫實踐的品質和安全，從而增強組織庫的信任和可靠性。

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

  • 組織庫市場的主要參與者正在積極參與各種策略性舉措，以增強其市場地位並推動創新。領先公司正在大力投資研發，以推動冷凍保存技術、改進組織儲存方法並開發組織樣本的新應用。這包括實施尖端的自動化和數位解決方案，以簡化操作、提高效率並確保生物材料的高品質保存。此外，這些參與者還透過建立新的組織庫並與學術機構、生物製藥公司和醫療保健組織建立策略性合作夥伴關係來擴大其全球足跡。為了滿足對專業且特徵明確的組織標本不斷成長的需求，主要參與者也致力於使其組織收藏多樣化並結合先進的基因組和分子表徵技術。此外，遵守法規和建立嚴格的品質控制標準是首要任務，確保其實踐符合國際準則並提高組織資源的可靠性。

組織銀行市場新聞：

  • 2023 年，美國組織庫協會 (AATB) 啟動了一項重大項目，旨在修訂和簡化其組織庫標準。該項目涉及與各個利益相關者的廣泛合作，以確保新標準易於使用且全面。
  • 2022 年 11 月，阿布達比健康部與總部位於美國的非營利性眼庫 Eversight 合作推出了阿拉伯聯合大公國首家眼科和組織庫。

本報告回答的關鍵問題

  • 2023 年全球組織庫市場規模有多大
  • 2024-2032年全球組織庫市場的預期成長率是多少
  • 推動全球組織銀行市場的關鍵因素是什麼
  • COVID-19 對全球組織庫市場有何影響
  • 基於產品的全球組織銀行市場的細分是什麼
  • 基於應用程式的全球組織銀行市場的細分是什麼
  • 根據組織類型，全球組織銀行市場的細分如何
  • 全球組織庫市場的關鍵區域有哪些
  • 誰是全球組織銀行市場的主要參與者/公司

本報告回答的關鍵問題

  • 2023 年全球組織庫市場規模有多大？ 2024-2032 年全球組織庫市場的預期成長率是多少？
  • 推動全球組織銀行市場的關鍵因素是什麼？
  • COVID-19 對全球組織庫市場有何影響？
  • 基於該產品的全球組織銀行市場的詳細情形如何？
  • 基於應用程式的全球組織銀行市場的細分是什麼？
  • 根據組織類型，全球組織銀行市場的細分如何？
  • 全球組織庫市場的關鍵區域有哪些？
  • 誰是全球組織銀行市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球組織庫市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 裝置
    • 市場趨勢
    • 關鍵環節
      • 超低溫保存設備
      • 解凍設備
      • 品質管制設備
      • 其他
    • 市場預測
  • 介質和耗材
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按應用

  • 療法
    • 市場趨勢
    • 市場預測
  • 醫學研究
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依組織類型

  • 心血管組織
    • 市場趨勢
    • 市場預測
  • 肺組織
    • 市場趨勢
    • 市場預測
  • 腎臟組織
    • 市場趨勢
    • 市場預測
  • 胰臟組織
    • 市場趨勢
    • 市場預測
  • 肝臟組織
    • 市場趨勢
    • 市場預測
  • 眼組織
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AMS Biotechnology
    • Beckman Coulter Inc. (Danaher Corporation)
    • Bio-Rad Laboratories Inc.
    • Brooks Life Sciences Inc. (Brooks Automation Inc.)
    • Eppendorf AG
    • Merck KGaA
    • PHC Corporation
    • QIAGEN NV
    • Sartorius AG
    • Taylor-Wharton
    • Thermo Fisher Scientific Inc.
    • VWR International LLC (Avantor Inc)
Product Code: SR112024A4764

The global tissue banking market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 10% during 2024-2032. The burgeoning research and development (R&D) investments, advancements in cryopreservation, the rise in chronic diseases and genetic disorders, growing demand for personalized medicine, improvements in genomics, regulatory advancements, strategic collaborations, and enhanced awareness among researchers are some of the factors boosting the market growth.

Tissue Banking Market Analysis:

  • Major Market Drivers: The global market for tissue banking is driven by the expediating progress in regenerative medicine and growing adoption of organ transplantation procedures. Increasing number of initiatives undertaken by the government and rising awareness regarding tissue donation are other factors expected to drive the market growth. Moreover, surging focus on the development of tissue preservation and storage techniques that are more viable and offer longer shelf life is another growth-inducing factor for the market. With the increasing rate of chronic diseases and trauma cases, the demand for tissue banking is growing exponentially, which is another factor stimulating the market growth. Apart from this, expanding healthcare infrastructure especially in developing countries is facilitating the market growth. Other factors, such as mounting investments into biobanking and personalized medicine and escalating collaborations among research institutions and tissue banks, are promoting the market growth.
  • Key Market Trends: The development of automated tissue processing and preservation systems, which has helped minimize the amount of time taken to do a process with reduced human error, is one of the primary market trends. The escalating use of artificial intelligence (AI) and machine learning (ML) in tissue banking to improve data management is creating a positive outlook for the market growth. In line with this, stringent ethical regulations has compelled the tissue baking players to standardize their operations, which is further fueling the market growth. Moreover, the escalating collaboration between biopharmaceutical companies and tissue banks and surging attention on the cryopreservation methods are propelling the market growth.
  • Geographical Trends: North America holds a leading share in the global tissue banking market as it is backed by a strong healthcare infrastructure, higher awareness about tissue donation, and significant investments in medical research. The region's dominance is also due to the strong presence of key market players and advanced technological capabilities. Europe's market growth is propelled by favorable governmental contexts and robust public health systems. Asia-Pacific's tissue banking market is bolstered by the burgeoning healthcare expenditure, expanding biobanking initiatives, and growing number of tissue transplantation.
  • Competitive Landscape: Some of the major market players in the tissue banking industry include AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., VWR International LLC (Avantor Inc), among many others.
  • Challenges and Opportunities: The factors creating challenges for the market include stringent regulatory requirements, ethical issues about tissue donation and processing, and the high costs of sophisticated storage methods. The quality and safety of stored tissues is aptly the primary concern, which entails adherence to stringent standards. Tissue donation rates are limited in some parts due to low level of awareness and cultural barriers. However, they also offer various opportunities for market development, such as the increasing tissue donation rates due to burgeoning public awareness and education. Affordability is another factor that preservation technology and storage solution providers can consider to address.

Tissue Banking Market Trends:

Increasing Investments in Research and Development

The global tissue banking market is predominantly driven in growth by the increasing investment in R&D, especially for regenerative medicine and personalized therapies. With the advancements in disease understanding and treatment by scientific and medical communities, there is a significant growth in tissue sample donations, which is further fueling the market growth. These samples are key to understanding the biology of disease, testing new drugs for potential use in patients, and identifying patient populations that may benefit from a particular drug. As research progresses in fields such as stem cell therapy and gene editing, it thrusts the reliance on specific tissue samples, further increasing the demand for well-preserved banks of tissues accessible by everyone. For instance, recently, UC San Francisco launched the world's first tissue bank with samples donated by patients with long COVID. The move follows research indicating that the virus can continue to linger throughout the body and may hold the key to understanding the cause of the debilitating disorder and lead to effective treatments.

Advances in Cryopreservation Technologies

The development of cryopreservation technologies is one of the major factors which is pushing the global tissue banking market. Cryopreservation is an effective way to store living tissue and cells below freezing temperatures while keeping it viable. Rapidly advancing technologies have accelerated this process, making the quality of preserved tissues and their durability much better. Additionally, new cryoprotectants and cooling techniques are developed, such as vitrification that prevents ice crystal formation, which can otherwise damage cell structures. Moreover, automation in cryopreservation further automates the operations and helps in minimizing human error and increasing throughput, which is bolstering the market growth.

Growing Prevalence of Chronic Diseases and Genetic Disorders

The growing incidence of genetic diseases and chronic conditions is one of the primary factor accelerating the global tissue banking market. As per the national survey carried out in Saudi population, Diabetes Mellitus (DM) among adult males and females were estimated with prevalence rates 14.8% for male, while it was lower for female group where 11.7%. Chronic conditions such as cancer, cardiovascular diseases, and diabetes require extensive research to understand their pathophysiology and develop effective treatments. Tissue banks provide critical resources for this research by offering a diverse array of biological samples, which are essential for studying disease mechanisms, developing new drugs, and testing treatment efficacy.

Tissue Banking Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and tissue type.

Breakup by Product:

  • Equipment
    • Cryopreservation Equipment
    • Thawing Equipment
    • Quality Control Equipment
    • Others
  • Media and Consumables

Equipment accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes equipment (cryopreservation equipment, thawing equipment, quality control equipment, others) and media and consumables. According to the report, equipment represented the largest segment.

The equipment segment is driven by the increasing demand for advanced and reliable systems for tissue preservation and analysis. Technological advancements, such as automation and improved cryopreservation techniques, are crucial in enhancing the efficiency and accuracy of tissue handling and storage. The rise in research activities and clinical trials necessitates state-of-the-art equipment to ensure high-quality and reproducible results. Additionally, the growing focus on personalized medicine and regenerative therapies fuels the need for specialized equipment capable of managing diverse and complex tissue samples. Regulatory requirements for quality and safety standards further drive the adoption of sophisticated equipment. Increased investments in healthcare infrastructure and the expansion of tissue banks globally also contribute to the demand for advanced equipment.

Breakup by Application:

  • Therapeutics
  • Medical Research
  • Others

Therapeutics holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes therapeutics, medical research, and others. According to the report, therapeutics accounted for the largest market share.

The therapeutics segment is driven by the increasing demand for personalized medicine, which necessitates the use of specific, high-quality tissue samples to tailor treatments to individual genetic profiles. Advances in genomics and biotechnology further fuel this growth, as they enable researchers and clinicians to better understand complex disease mechanisms and develop targeted therapies. Additionally, the rising prevalence of chronic diseases and genetic disorders accelerates the need for innovative therapeutic solutions, leading to a surge in research and development activities. Technological advancements in drug discovery, including high-throughput screening and sophisticated bioinformatics tools, are also pivotal, as they rely on diverse and well-characterized biological samples to identify and validate new therapeutic targets. The growing emphasis on regenerative medicine and cell therapies, such as stem cell treatments and tissue engineering, drives demand for robust tissue banking infrastructure, which provides essential materials for these cutting-edge therapies.

Breakup by Tissue Type:

  • Cardiovascular Tissue
  • Lung Tissue
  • Kidney Tissue
  • Pancreas Tissue
  • Liver Tissue
  • Eye Tissue
  • Others

Cardiovascular Tissue represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the tissue type. This includes cardiovascular tissue, lung tissue, kidney tissue, pancreas tissue, liver tissue, eye tissue, and others. According to the report, cardiovascular tissue represented the largest segment.

The cardiovascular tissue segment is driven by the increasing prevalence of cardiovascular diseases (CVDs), which are among the leading causes of mortality globally. This surge in CVD cases necessitates extensive research and development efforts, fueling the demand for high-quality cardiovascular tissues for studying disease mechanisms, developing innovative treatments, and testing therapeutic interventions. Advances in tissue engineering and regenerative medicine are also pivotal, as they enable the creation and use of cardiovascular tissues for developing personalized therapies and improving patient outcomes. The growing emphasis on personalized medicine further drives demand, as clinicians seek tissue samples that match individual patient profiles for more effective treatment plans. Additionally, ongoing advancements in biobanking technologies, including improved preservation methods and better tissue characterization techniques, enhance the quality and availability of cardiovascular tissues.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest tissue banking market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for tissue banking.

The North America regional market is driven by the increasing investments in healthcare research and biotechnology, which significantly bolster the demand for high-quality tissue samples. The presence of advanced research institutions and a robust pharmaceutical industry in the region accelerates the need for well-maintained tissue banks to support innovative studies in regenerative medicine, personalized therapies, and drug development. Additionally, the growing prevalence of chronic diseases and genetic disorders in North America drives the need for diverse tissue samples to understand disease mechanisms and develop effective treatments. Technological advancements in cryopreservation and tissue storage further enhance the market, providing solutions that extend the viability of preserved tissues and improve overall research quality. The regulatory landscape in North America also plays a crucial role; stringent standards and guidelines ensure the quality and safety of tissue banking practices, which in turn fosters trust and reliability in tissue banks.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the tissue banking industry include AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., VWR International LLC (Avantor Inc), etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • Key players in the tissue banking market are actively engaged in a variety of strategic initiatives to enhance their market position and drive innovation. Leading companies are investing heavily in R&D to advance cryopreservation technologies, improve tissue storage methods, and develop new applications for tissue samples. This includes implementing cutting-edge automation and digital solutions to streamline operations, increase efficiency, and ensure high-quality preservation of biological materials. Additionally, these players are expanding their global footprint by establishing new tissue banks and forming strategic partnerships with academic institutions, biopharmaceutical companies, and healthcare organizations. To address the growing demand for specialized and well-characterized tissue specimens, key players are also focusing on diversifying their tissue collections and incorporating advanced genomic and molecular characterization techniques. Moreover, regulatory compliance and the establishment of rigorous quality control standards are priorities, ensuring that their practices meet international guidelines and enhance the reliability of tissue resources.

Tissue Banking Market News:

  • In 2023, The American Association of Tissue Banks (AATB) has initiated a significant project aimed at revising and streamlining its Standards for Tissue Banking. This project involves extensive collaboration with various stakeholders to ensure the new standards are user-friendly and comprehensive.
  • In November 2022, Abu Dhabi's Department of Health and Eversight, a U.S.-based non-profit eye bank, collaborated to launch the UAE's inaugural Eye and Tissue Bank.

Key Questions Answered in This Report

  • 1. What was the size of the global tissue banking market in 2023?
  • 2. What is the expected growth rate of the global tissue banking market during 2024-2032?
  • 3. What are the key factors driving the global tissue banking market?
  • 4. What has been the impact of COVID-19 on the global tissue banking market?
  • 5. What is the breakup of the global tissue banking market based on the product?
  • 6. What is the breakup of the global tissue banking market based on the application?
  • 7. What is the breakup of the global tissue banking market based on the tissue type?
  • 8. What are the key regions in the global tissue banking market?
  • 9. Who are the key players/companies in the global tissue banking market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tissue Banking Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Cryopreservation Equipment
      • 6.1.2.2 Thawing Equipment
      • 6.1.2.3 Quality Control Equipment
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Media and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Medical Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Tissue Type

  • 8.1 Cardiovascular Tissue
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Lung Tissue
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Kidney Tissue
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pancreas Tissue
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Liver Tissue
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Eye Tissue
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AMS Biotechnology
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Brooks Life Sciences Inc. (Brooks Automation Inc.)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Eppendorf AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 PHC Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 QIAGEN N.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sartorius AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Taylor-Wharton
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 VWR International LLC (Avantor Inc)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Tissue Banking Market: Major Drivers and Challenges
  • Figure 2: Global: Tissue Banking Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Tissue Banking Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Tissue Banking Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Tissue Banking Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Tissue Banking Market: Breakup by Tissue Type (in %), 2023
  • Figure 7: Global: Tissue Banking Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Tissue Banking (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Tissue Banking (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Tissue Banking (Media and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Tissue Banking (Media and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Tissue Banking (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Tissue Banking (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Tissue Banking (Medical Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Tissue Banking (Medical Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Tissue Banking (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Tissue Banking (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Tissue Banking (Cardiovascular Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Tissue Banking (Cardiovascular Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Tissue Banking (Lung Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Tissue Banking (Lung Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Tissue Banking (Kidney Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Tissue Banking (Kidney Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Tissue Banking (Pancreas Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Tissue Banking (Pancreas Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Tissue Banking (Liver Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Tissue Banking (Liver Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Tissue Banking (Eye Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Tissue Banking (Eye Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Tissue Banking (Other Tissue Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Tissue Banking (Other Tissue Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Tissue Banking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Tissue Banking Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Tissue Banking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Tissue Banking Industry: SWOT Analysis
  • Figure 82: Global: Tissue Banking Industry: Value Chain Analysis
  • Figure 83: Global: Tissue Banking Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Tissue Banking Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Tissue Banking Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Tissue Banking Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Tissue Banking Market Forecast: Breakup by Tissue Type (in Million US$), 2024-2032
  • Table 5: Global: Tissue Banking Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Tissue Banking Market: Competitive Structure
  • Table 7: Global: Tissue Banking Market: Key Players